# Chemotherapy and Stem Cell Transplantation in Treating Children With Central Nervous System Cancer

> **NCT00053118** · PHASE1 · COMPLETED · sponsor: **Roswell Park Cancer Institute** · enrollment: 1 (actual)

## Conditions studied

- Brain and Central Nervous System Tumors
- Lymphoma
- Neuroblastoma
- Retinoblastoma

## Interventions

- **BIOLOGICAL:** filgrastim
- **DRUG:** carboplatin
- **DRUG:** etoposide
- **PROCEDURE:** bone marrow ablation with stem cell support
- **PROCEDURE:** peripheral blood stem cell transplantation

## Key facts

- **NCT ID:** NCT00053118
- **Lead sponsor:** Roswell Park Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-03
- **Primary completion:** 2004-07
- **Final completion:** 2004-07
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2011-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00053118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00053118, "Chemotherapy and Stem Cell Transplantation in Treating Children With Central Nervous System Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00053118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*